Advertisement
Screener

Immune Design Corp. Operating Income

Immune Design Corp. Operating Income

Immune Design Corp. reported Operating Income of -$57.05 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-13.

Discontinued › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2019-03-13

  • Immune Design Corp. operating income (loss) for the quarter ending 2018-12-31 was -$14.21M.
  • Immune Design Corp. operating income (loss) for the quarter ending 2018-09-30 was -$14.64M.
  • Immune Design Corp. operating income (loss) for the quarter ending 2018-06-30 was -$14.39M.
  • Immune Design Corp. operating income (loss) for the quarter ending 2018-03-31 was -$13.81M.
  • Immune Design Corp. operating income (loss) for fiscal 2018 was -$57.05M.
  • Immune Design Corp. operating income (loss) for fiscal 2017 was -$52.81M.
  • Immune Design Corp. operating income (loss) for fiscal 2016 was -$54.21M.
  • Immune Design Corp. operating income (loss) for fiscal 2015 was -$39.48M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2018-12-31-$14.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
-$28.85M
derived: sum of 2 quarters · filed 2019-03-13
-$43.24M
derived: sum of 3 quarters · filed 2019-03-13
-$57.05M
10-K · filed 2019-03-13
2018-09-30-$14.64M
10-Q · filed 2018-11-06
-$29.03M
derived: sum of 2 quarters · filed 2018-11-06
-$42.84M
10-Q · filed 2018-11-06
-$55.21M
derived: sum of 4 quarters · filed 2019-03-13
2018-06-30-$14.39M
10-Q · filed 2018-08-01
-$28.20M
10-Q · filed 2018-08-01
-$40.57M
derived: sum of 3 quarters · filed 2019-03-13
-$54.23M
derived: sum of 4 quarters · filed 2019-03-13
2018-03-31-$13.81M
10-Q · filed 2018-05-03
-$26.18M
derived: sum of 2 quarters · filed 2019-03-13
-$39.84M
derived: sum of 3 quarters · filed 2019-03-13
-$53.88M
derived: sum of 4 quarters · filed 2019-03-13
2017-12-31-$12.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
-$26.03M
derived: sum of 2 quarters · filed 2019-03-13
-$40.07M
derived: sum of 3 quarters · filed 2019-03-13
-$52.81M
10-K · filed 2019-03-13
2017-09-30-$13.65M
10-Q · filed 2018-11-06
-$27.70M
derived: sum of 2 quarters · filed 2018-11-06
-$40.44M
10-Q · filed 2018-11-06
-$54.96M
derived: sum of 4 quarters · filed 2019-03-13
2017-06-30-$14.04M
10-Q · filed 2018-08-01
-$26.79M
10-Q · filed 2018-08-01
-$41.31M
derived: sum of 3 quarters · filed 2019-03-13
-$53.90M
derived: sum of 4 quarters · filed 2019-03-13
2017-03-31-$12.74M
10-Q · filed 2018-05-03
-$27.27M
derived: sum of 2 quarters · filed 2019-03-13
-$39.86M
derived: sum of 3 quarters · filed 2019-03-13
-$54.32M
derived: sum of 4 quarters · filed 2019-03-13
2016-12-31-$14.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
-$27.12M
derived: sum of 2 quarters · filed 2019-03-13
-$41.57M
derived: sum of 3 quarters · filed 2019-03-13
-$54.21M
10-K · filed 2019-03-13
2016-09-30-$12.59M
10-Q · filed 2017-11-01
-$27.05M
derived: sum of 2 quarters · filed 2017-11-01
-$39.69M
10-Q · filed 2017-11-01
-$51.83M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30-$14.45M
10-Q · filed 2017-08-02
-$27.10M
10-Q · filed 2017-08-02
-$39.24M
derived: sum of 3 quarters · filed 2018-03-14
-$46.65M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31-$12.64M
10-Q · filed 2017-05-04
-$24.78M
derived: sum of 2 quarters · filed 2018-03-14
-$32.20M
derived: sum of 3 quarters · filed 2018-03-14
-$42.72M
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31-$12.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
-$19.55M
derived: sum of 2 quarters · filed 2018-03-14
-$30.08M
derived: sum of 3 quarters · filed 2018-03-14
-$39.48M
10-K · filed 2018-03-14
2015-09-30-$7.41M
10-Q · filed 2016-11-09
-$17.94M
derived: sum of 2 quarters · filed 2016-11-09
-$27.34M
10-Q · filed 2016-11-09
-$40.47M
derived: sum of 4 quarters · filed 2017-03-07
2015-06-30-$10.53M
10-Q · filed 2016-08-09
-$19.93M
10-Q · filed 2016-08-09
-$33.05M
derived: sum of 3 quarters · filed 2017-03-07
-$39.61M
derived: sum of 4 quarters · filed 2017-03-07
2015-03-31-$9.41M
10-Q · filed 2016-05-10
-$22.53M
derived: sum of 2 quarters · filed 2017-03-07
-$29.08M
derived: sum of 3 quarters · filed 2017-03-07
-$33.77M
derived: sum of 4 quarters · filed 2017-03-07
2014-12-31-$13.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07
-$19.68M
derived: sum of 2 quarters · filed 2017-03-07
-$24.36M
derived: sum of 3 quarters · filed 2017-03-07
-$29.88M
10-K · filed 2017-03-07
2014-09-30-$6.56M
10-Q · filed 2015-11-12
-$11.24M
derived: sum of 2 quarters · filed 2015-11-12
-$16.76M
10-Q · filed 2015-11-12
-$21.21M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30-$4.69M
10-Q · filed 2015-08-12
-$10.20M
10-Q · filed 2015-08-12
-$14.65M
derived: sum of 3 quarters · filed 2016-03-15
-$18.65M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31-$5.51M
10-Q · filed 2015-05-14
-$9.97M
derived: sum of 2 quarters · filed 2016-03-15
-$13.96M
derived: sum of 3 quarters · filed 2016-03-15
-$17.60M
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31-$4.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
-$8.45M
derived: sum of 2 quarters · filed 2016-03-15
-$12.09M
derived: sum of 3 quarters · filed 2016-03-15
-$15.06M
10-K · filed 2016-03-15
2013-09-30-$3.99M
10-Q · filed 2014-11-13
-$7.63M
derived: sum of 2 quarters · filed 2014-11-13
-$10.60M
10-Q · filed 2014-11-13
2013-06-30-$3.64M
10-Q · filed 2014-09-08
-$6.61M
10-Q · filed 2014-09-08
2012-12-31-$10.88M
10-K · filed 2015-03-31